名稱 | ADCP Bioassay Effector Cell FcγRIa_NFAT/Jurkat |
型號(hào) | CBP74105 |
報(bào)價(jià) | ![]() |
特點(diǎn) | ADCP Bioassay Effector Cell FcγRIa_NFAT/Jurkat,母細(xì)胞:Jurkat,凍存條件:90% FBS+10% DMSO |
產(chǎn)品搜索
相關(guān)文章
- Western Blot標(biāo)準(zhǔn)操作流程
- 細(xì)胞株的緩沖液有哪些用途?
- 慢病毒整合位點(diǎn)標(biāo)準(zhǔn)品強(qiáng)勢(shì)來(lái)襲
- CD27藥物細(xì)胞篩選模型
- atcc細(xì)胞庫(kù)的常見(jiàn)冷藏技術(shù)簡(jiǎn)介
- *針對(duì)肝癌的PD-1抗體獲FDA批準(zhǔn),國(guó)產(chǎn)PD-1抗體進(jìn)入三期
- IgE:過(guò)敏與免疫的“雙面分子”
- KIR3DL3/HHLA2細(xì)胞篩選模型
- 雙面PD1,Blocker已成卷王,agonist賽道你上車了嗎?
- 耐藥ATCC細(xì)胞株如何構(gòu)建看完就會(huì)知道
聯(lián)系我們
聯(lián)系人:蔣經(jīng)理
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > 腫瘤免疫細(xì)胞株 > CBP74105ADCP Bioassay Effector Cell FcγRIa_NFAT/Jurkat

- 詳細(xì)內(nèi)容
CBP74105 | |
I. Background | |
Antibody-dependent cell-mediated phagocytosis (ADCP) is one of the important mechanisms of action for antibody drug development. | |
II. Introduction | |
Host Cell: | Jurkat |
Expressed gene: | FcγRIa_NFAT |
Stability: | 32 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Synonym(s): | N/A |
Freeze Medium: | 90% FBS+10% DMSO |
Culture Medium: | RPMI-1640+10%FBS+1ug/ml puromycin+800ug/ml hygromycin |
Storage: | Liquid nitrogen. |
Application(s): | Functional(Report Gene) Assay |
III. Description of Host Cell Line | |
Organism: | Human |
Tissue: | Peripheral blood |
Disease: | Childhood T acute lymphoblastic leukemia |
Morphology: | Lymphoblast |
Growth Properties: | Suspension |
IV.Representative Data | |
Figure 1:Dose response of Rituximab in ADCP Bioassay Effector Cell FcγRIa/NFAT Reporter-Jurkat (C11),the EC50 was 1.94ng/ml. |